Dec. 28, 2024: cosibelimab Checkpoint Therapeutics resubmitted an application for its anti-programmed death ligand-1 (PD-L1) antibody, cosibelimab, for the treatment for adults with metastatic or...

Publications Clinical Highlights: April 2025 Your monthly source for drug information highlights. Shortage updates The U.S. Government Accountability Office (GAO) has published a report on drug...

cover image Tracking the therapies shaping tomorrow’s care Prime Therapeutics /cell-gene-pipeline-outlook-november-2025 Prime Therapeutics’ Cell & Gene Pipeline Outlook is an industry report that...

Drug Approvals Monthly Update: March 2024 Traditional New drugs 3/04/2024 clobetasol propionate 0.05% The FDA approved the first clobetasol propionate ophthalmic formulations. The 0.05% suspension...

U.S. News & World Report

In the latest episode of the “Pharmacy Friends” podcast, hear from Prime Therapeutics experts about how the fast-moving pipeline is changing how patients, providers and payers prepare for...

PUBLICATIONS FDA Decisions Expected: August 2025 Your monthly synopsis of new drugs expected to hit the market All brand names are property of their respective owners. References Press release:...

From research posters and education sessions to the Pharmacy Friends podcast, Prime has you covered on the latest managed care pharmacy insights

Journal of Managed Care & Specialty Pharmacy (JMCP)

Unlock high-touch outreach Help members and their prescribers make better decisions about medicines through this clinical intelligence hub that delivers actionable insights, flexible levels of data...

Learn with Biosimilar Basics. Part 1 starts with an overview of biosimilar products, sharing what biosimilar drugs are and the difference vs generic drugs.

Insights from Academy of Managed Care Pharmacy (AMCP) Nexus 2023

A roundup of Prime's award-winning presentations and insights at AMCP Annual Meeting in Houston

Experience pharmacy solutions built for you Get holistic, people-centered solutions that help you save money while delivering a better member experience. How PBMs deliver results Prime’s Save,...

In the latest episode of the “Pharmacy Friends” podcast, join Prime’s research team for a preview of the industry-leading and award-winning research that will be presented at flagship industry event

Studies include Prime’s GLP-1 obesity research and a Medicare drug cost predictive model

Prime Therapeutics clinical experts shared insights on the specialty drug pipeline at recent industry event

In this episode, Prime/MRx clinicians — along with special guests — discuss the hottest topics covered at the Academy of Managed Care Pharmacy (AMCP)'s 2024 Annual Meeting in New Orleans

New indications for approved gene / cell therapy products - 2024 Generic Name Brand Name Manufacturer Indication(s) Route of Administration Month Approved* fidanacogene elaparvovec-dzkt Beqvez™...

Industry experts share new insights from PBM industry, including GLP-1 weight-loss drugs, biosimilars and rising pharmaceutical costs